Jan 25,2022

OncoHealth Continues Significant Revenue, Membership, Employee Growth and Innovation in Successful 2021

OncoHealth™, the leading digital health company focused on the physical, mental and financial complexities of cancer care, combined a driving commitment to innovation and a patient-first treatment approach to continue its accelerated growth in 2021. Key growth milestones achieved for the just-concluded fiscal year included: Growing GAAP revenue by 43%; Employee count surpassing 200, with key hires across the organization, Adding 1.2 million new members on the OncoHealth OneUM™ digital oncology platform; and more.

View Analyst & Ambassador Comments
Go to original news
Jan 21,2022

Feasibility and acceptability of virtual reality for cancer pain in people receiving palliative care: a randomised cross-over study

Pain management in palliative care remains inadequate; the development of innovative therapeutic options is needed. The objective of the stduy is to determine the feasibility and preliminary effectiveness for larger randomised controlled trials of 3D head-mounted (HMD) virtual reality (VR) for managing cancer pain (CP) in adults.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 27,2022

Players Needed to Solve Puzzles and Help Advance Cancer Research

The CRG and CNAG-CRG have launched GENIGMA, a videogame that enlists players to solve puzzles while generating real-world scientific data that can detect alterations in genomic sequences and ultimately advance breast cancer research. The game, out today on iOS and Android and available in English, Spanish, Catalan and Italian, is the result of a two-and-a-half-year long citizen science project developed by a team of researchers at the Centre for Genomic Regulation (CRG), the Centro Nacional de Análisis Genómico (CNAG-CRG) and game professionals.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 11,2022

Helping Cancer Patients Avoid Excessive Radiation

A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to identify which patients with certain head and neck cancers would benefit from reducing the intensity of treatments such as radiation therapy and chemotherapy. The researchers used AI tools similar to those they developed over the last decade at the Center for Computational Imaging and Personal Diagnostics (CCIPD) at Case Western Reserve.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 25,2022

The First AI Breast Cancer Sleuth that Shows its Work

Computer engineers and radiologists at Duke University have developed an artificial intelligence (AI) platform to analyze potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy. But unlike its many predecessors, this algorithm is interpretable, meaning it shows physicians exactly how it came to its conclusions.

CLINICAL STUDY

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Jan 04,2022

Smartphone-based application for self-management of patients with colorectal cancer: development and usability evaluation

Self-management is considered essential for improving the treatment and management of colorectal cancer patients. This study was conducted to develop and evaluate the usability of a smartphone-based application for the self-management of patients with colorectal cancer.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 07,2022

IBM reportedly shopping Watson Health just as healthcare gets hot

IBM could be looking to sell the Watson Health division for a mere $1 billion, according to an Axios report. The question is why is IBM running away from the healthcare vertical just as it seems to be heating up, and for such a low price?

View Analyst & Ambassador Comments
Go to original news
Jan 01,2022

Flatiron Health Announces RWD Partnership with Japan’s NCCHE

Flatiron Health today announced a partnership with Japan’s National Cancer Center Hospital East (NCCHE) to build a real-world database of patients with gastro-intestinal cancers. Under the agreement signed with Flatiron Health K.K., real-world data (RWD) chronicling the aggregated and de-identified experiences of consented NCCHE patients will be curated into top-quality datasets for use by NCCHE to support its research and treatment decisions, and by other researchers and regulatory decision-makers to help answer previously unanswerable questions.

COLLABORATION PARTNERSHIP

#institution

#rwd

View Analyst & Ambassador Comments
Go to original news
Jan 03,2022

The Mounting Evidence for Home-Centered Cancer Care.

Aaron Gerber, CEO of Reimagine Care, reflects on the home-centered cancer care services.

View Analyst & Ambassador Comments
Go to original news
Jan 06,2022

Voluntis and AliveCor Partner to Advance Management of Atrial Fibrillation for Patients with Cancer

Voluntis, an Aptar Pharma company and leader in digital therapeutics, today announced that it has entered into a partnership agreement with AliveCor, Inc. (AliveCor), a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology. Under the collaboration, AliveCor’s KardiaMobile device will be integrated with Theraxium, Voluntis’ regulated platform for digital therapeutics (DTx), to help address the challenges associated with cardiotoxicity management for patients undergoing cancer treatment and facilitate remote self-monitoring for atrial fibrillation (AFib).

COLLABORATION PARTNERSHIP

#connected device

#platform

#dtx

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY